Hostname: page-component-89b8bd64d-4ws75 Total loading time: 0 Render date: 2026-05-06T17:33:37.601Z Has data issue: false hasContentIssue false

Subsidy Incidence in Privately Negotiated Spot Markets: Experimental Evidence

Published online by Cambridge University Press:  07 February 2019

Mohammad Maksudur Rahman
Affiliation:
School of Economic Sciences, Washington State University, Pullman, Washington, USA
Christopher T. Bastian*
Affiliation:
Department of Economics, University of Wyoming, Laramie, Wyoming, USA
Chian Jones Ritten
Affiliation:
Department of Economics, University of Wyoming, Laramie, Wyoming, USA
Owen R. Phillips
Affiliation:
Department of Economics, University of Wyoming, Laramie, Wyoming, USA
*
Rights & Permissions [Opens in a new window]

Abstract

We use experimental methods to investigate subsidy incidence, the transfer of subsidy payments from intended recipients to other economic agents, in privately negotiated spot markets. Our results show that market outcomes in treatments with a subsidy given to either buyers or sellers are significantly different from both a no-subsidy treatment and the competitive prediction of a 50% subsidy incidence. The disparity in incidence across treatments relative to predicted levels suggests that incidence equivalence does not hold in this market setting. Moreover, we find no statistical difference in market outcomes when benefits are framed as a “subsidy” versus a schedule shift.

Information

Type
Research Article
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
© The Author(s) 2019
Figure 0

Table 1. Seller and buyer schedules for different treatments

Figure 1

Table 2. Predicted equilibria in different treatments

Figure 2

Figure 1. Aggregated supply and demand functions for different treatments.

Figure 3

Table 3. Estimates for market outcomes across treatments

Figure 4

Figure 2. Price trends across treatments.

Figure 5

Figure 3. Trends in units traded across treatments.